抗胆固醇药物负担量表:系统性审查
Orla Vennard1,2, Carrie Stewart2, Mansi Tolia1,3
1School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK.
Journal of the American Geriatrics Society
|February 23, 2026
概括
没有一个单一的抗胆固醇负担量表被普遍接受. 本次审查强调需要一个标准化的系统来准确评估抗胆固醇药物的风险,并提高患者的安全.
科学领域:
- 药理学 药理学 是一个学科.
- 老年病的医生 老年病的医生
- 临床药房 临床药房
背景情况:
- 抗胆固醇负担 (ACB) 是抗胆固醇特性药物的累积效应.
- ACB尺度有助于识别患有不良反应风险的患者,并指导处方实践.
- 现有的ACB尺度表现出显著的变化,缺乏公认的黄金标准,这可能导致不一致的风险评估和低于最佳的患者护理.
研究的目的:
- 系统地审查抗胆固醇负担量表,检查它们的药物清单,开发和评分方法.
- 总结与不同抗胆固醇药物负担量表相关的临床结果.
主要方法:
- 进行了系统的文献搜索,直到2025年1月,包括提出新型或更新的ACB尺度的研究.
- 由两名审稿人使用基于专家共识的定制工具进行独立审查和数据提取.
- 来自21项纳入研究的研究结果的叙述综合.
主要成果:
- 在包含的药物数量 (27-217) 和高效药物的评分 (74%不一致) 中存在显著的变化.
- 规模开发通常依赖于文献审查和专家意见,地理来源和方法影响了变化.
- 对诸如剂量等因素的不一致考虑影响了临床相关性,正如结果研究所反映的那样.
结论:
- 在审查中没有确定最终的黄金标准抗胆固醇药物负担量表.
- 具有全面药物覆盖和考虑个体变异性的尺度似乎在临床上更相关.
- 需要一个通用的,临床上可访问的评分系统,以减轻抗胆固醇多药的风险.
相关概念视频
Cholinergic Antagonists: Therapeutic Uses
1.6K
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.6K
Cholinergic Antagonists: Pharmacological Actions
1.8K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.8K
Cholinergic Antagonists: Pharmacokinetics
1.0K
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
1.0K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.7K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Drug Dosing: Geriatric Patients
319
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
319
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K


